Dihydroartemisinin Drives SP1 Degradation to Slow Melanoma Growth
A new study reports that dihydroartemisinin suppresses melanoma by promoting ubiquitination and proteasomal degradation of the transcription factor SP1.
A new study reports that dihydroartemisinin suppresses melanoma by promoting ubiquitination and proteasomal degradation of the transcription factor SP1.
Researchers propose a structured decision matrix to guide the selection of outcome measures in health economic evaluations of skin cancer ...
BRAF inhibitor-resistant melanoma cells release M-CSF and remodel the immune microenvironment, and blocking this signal improved drug efficacy in mouse ...
A mixed methods Australian study found that most community members and patients who used validated online melanoma risk prediction tools ...
A four-site US chart review of 398 patients with stage IB–IIC melanoma found predominantly surgical management, with systemic therapy and ...
A new study in Myeloid Cells reports that the vaccine adjuvant AS01 induces trained immunity in human monocytes and slows ...
Endothelial ICAM-1 becomes polarized to the tumor periphery as melanomas grow, trapping T cells at the margins, and blocking it ...
Sustained blood CXCL1 elevation tracked attenuated Salmonella colonization in four preclinical tumor models.
A UK retrospective cohort study of 133 patients with loco-regional recurrent melanoma found surgery was the predominant treatment, with immunotherapy ...
A new editorial argues that extracellular vesicles both drive tumor adaptation and drug resistance and offer promising platforms for antitumor ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine